Luvesilocin: This new psychedelic drug could change how we treat postpartum depression
In recent FDA Phase 2 trials, a single dose of the experimental psychedelic luvesilocin eliminated postpartum depression symptoms in 71% of patients within seven days. The breakthrough medication…
Read the full articleYou might also wanna read
Nearly 20% of new moms have anxiety or depression, but a promising psychedelic treatment is on the horizon
Luvesilocin could change postpartum care. The post Nearly 20% of new moms have anxiety or depression, but a promising psychedelic treatment
Luvesilocin in FDA-Phase-2: Schnell wirksam gegen Postpartum-Depression?
DENVER / LONDON (IT BOLTWISE) – Die FDA hat Luvesilocin den Status „Breakthrough Therapy“ gegeben, weil eine Phase-2-Studie bei Postpartum-D
The experimental drug that could change how postpartum depression is treated
About 1 in 5 women will experience depression and anxiety during pregnancy or in the year after giving birth
Synthetic Psilocybin Shows Strong Results in Treatment-Resistant Depression Trials
Regulators are now mulling the results of the late-stage trial
economist.com·4mo ago
Real-World Study Shows Psilocybin Improves Treatment-Resistant Depression Symptoms
One of the first real-world studies of psilocybin therapy suggests meaningful improvements in treatment-resistant depression outside the con
mdsc.pe·12d ago
Severe Alzheimer's patient shows improved cognition and speech after psilocybin dose
A woman with severe Alzheimer's disease who hadn't spoken more than monosyllables in years began initiating conversation after a single dose
newscientist.com·12d agoSevere Alzheimer's patient shows improved cognition and speech after psilocybin dose
A woman with severe Alzheimer's disease who hadn't spoken more than monosyllables in years began initiating conversation after a single dose
newscientist.com·12d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.